Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is a once-weekly subcutaneous injection taken at the same time each week, starting at 2.5 mg and increased gradually by your prescriber. Each pre-filled KwikPen holds four weekly doses, and the medicine works alongside a reduced-calorie diet and regular physical activity. Because Mounjaro is a prescription-only medicine, a prescriber decides your dose and schedule — not the packet, and not an online calculator. If you're staring at your first pen feeling less than certain about what you're doing, that's completely normal; almost everyone does.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misunderstanding about taking Mounjaro for weight loss is that the injection does all the work on its own. It doesn't, and setting that expectation straight early saves a lot of frustration. Mounjaro is a dual GIP and GLP-1 receptor agonist (it slows gastric emptying and signals fullness more strongly) but those effects are meant to support changes to how you eat and move, not replace them. The NHS tirzepatide guidance is clear that the medicine is licensed alongside a reduced-calorie diet and increased physical activity. Skipping that context doesn't just slow results; it may mean the medicine never performs as it did in trials.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, saw participants lose an average of around 20–21% of body weight at the 15 mg dose over 72 weeks, but those participants were also receiving dietary and lifestyle support throughout. If you want a full walkthrough of dosing, timing, and what to do on injection day, our guide on how to take tirzepatide for weight loss covers every step in practical detail. Our clinical team flags this from the first consultation precisely because it changes how people experience the early weeks.
Wash your hands thoroughly. Take the pen from the fridge and let it sit at room temperature for around 30 minutes, injecting cold medicine can sting more. Choose your site: abdomen (at least a couple of centimetres from your navel), front thigh, or outer upper arm. Clean the skin if you wish, though the evidence base for alcohol swabs before subcutaneous injection is modest; if you'd like to use them, pre-cut swabs make it straightforward. Let the skin dry completely before you inject, wet skin can increase discomfort.
Remove the pen cap. Hold the pen flat against your skin at a 90-degree angle; press firmly, then press and hold the injection button until you hear the click and the grey plunger has fully descended in the window. Keep it pressed for at least five seconds before removing. That five-second hold is the step people most often rush, and rushing it is the most common reason for incomplete doses. Do not recap or reuse needles. Dispose of used pens in a proper sharps container, household bins are not safe or legal for sharps. Rotate your site weekly; injecting the same spot repeatedly leads to lipohypertrophy, which can affect how the medicine is absorbed. For more detail on choosing and alternating sites, see our guide on where to inject Mounjaro.
Gastrointestinal effects are the most common: nausea, loose stools, constipation, reflux, and burping tend to peak in the days after a dose increase and usually settle within a couple of weeks. Eating smaller meals, avoiding very fatty or spicy food during the adjustment period, and staying well hydrated all help. These effects are why the 2.5 mg starting dose exists, your system needs time to adapt before the dose moves up.
Most people find them manageable. Some don't. If vomiting or diarrhoea is severe enough to stop you keeping fluids down, contact a clinician the same day; dehydration can affect the kidneys. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as an infrequent but serious risk: if you develop severe stomach pain that spreads to your back, particularly with vomiting, seek urgent medical attention rather than waiting to see whether it settles. Any suspected side effect can be reported to the MHRA Yellow Card scheme. Missed doses, decisions about whether to continue after a reaction, and any changes to your timing should always go through your prescriber, never be adjusted based on forums or social media.
If you're curious about how long it typically takes before you notice results, our page on how long Mounjaro takes to work covers the trial evidence in detail. And for the full picture on storing your pen safely between uses, Mounjaro refrigeration requirements explains exactly what the SmPC says.
Mounjaro's titration schedule is structured the way it is for a reason, not as a bureaucratic delay. The 2.5 mg starting dose settles your system; the jump to 5 mg and beyond is where most people begin noticing meaningful appetite change. Your prescriber will only move your dose up when they're confident you've tolerated the current one, and when they've reviewed evidence of your progress, which at nume means every repeat order goes through a fresh clinical review, not an automatic reorder.
Rushing the titration, or skipping doses to try to 'save' a pen, undermines both safety and results. Similarly, stopping the medicine abruptly once you've hit a lower weight tends to reverse progress over time; long-term plans should be discussed with your prescriber as part of ongoing aftercare. You can find more context about the medicine's broader evidence base on our Mounjaro injection overview. If you're still at the stage of exploring whether this is the right treatment for you, the treatment options page is a good place to start before booking a consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.